MyFinsight
Home
Blog
About
Contact
Download
Download image
Thereafter
$5,300K
2029
$3,180K
2028
$3,180K
2027
$3,180K
2026
$3,180K
2025 (remaining)
$795K
Prepaid expenses and
other current assets
$14,633K
Inventory
$7,061K
Accounts receivable, net
$16,697K
Short-term investments
$408,303K
Cash and cash
equivalents
$43,277K
Deposits and other
long-term assets
$317K
Intangible assets, net
$18,815K
Operating
leaseright-of-useasset
$2,450K
Property and equipment,
net
$2,227K
Total current assets
$489,971K
Total assets
$513,780K
Total liabilities and
stockholders' equity
$513,780K
Total stockholders'
equity
$450,868K
Total liabilities
$62,912K
Accumulated deficit
-$640,125K
Accumulated other
comprehensive income
$69K
Additionalpaid-in-capital
$1,090,914K
Other long-term
liability
$761K
Long-term portion of
operating lease...
$2,732K
Long-term portion of
deferred revenue
$2,953K
Total current
liabilities
$56,466K
Common stock, 0.0001
par value...
$10K
Current portion of
operating lease...
$161K
Current portion of
deferred revenue
$2,317K
Accrued expenses and
other current...
$48,210K
Accounts payable
$5,778K
Back
Back
Balance Sheet
source: myfinsight.com
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)